Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Brain Structure and Function
Published in: Brain Structure and Function 3/2019

Open Access 01-04-2019 | Original Article

Genetic labeling reveals temporal and spatial expression pattern of D2 dopamine receptor in rat forebrain

Authors: Qing Yu, Ying-Zi Liu, Yan-Bing Zhu, Yao-Yi Wang, Qian Li, Dong-Min Yin

Published in: Brain Structure and Function | Issue 3/2019

Login to get access

Abstract

The D2 dopamine receptor (Drd2) is implicated in several brain disorders such as schizophrenia, Parkinson’s disease, and drug addiction. Drd2 is also the primary target of both antipsychotics and Parkinson’s disease medications. Although the expression pattern of Drd2 is relatively well known in mouse brain, the temporal and spatial distribution of Drd2 is lesser clear in rat brain due to the lack of Drd2 reporter rat lines. Here, we used CRISPR/Cas9 techniques to generate two knockin rat lines: Drd2::Cre and Rosa26::loxp-stop-loxp-tdTomato. By crossing these two lines, we produced Drd2 reporter rats expressing the fluorescence protein tdTomato under the control of the endogenous Drd2 promoter. Using fluorescence imaging and unbiased stereology, we revealed the cellular expression pattern of Drd2 in adult and postnatal rat forebrain. Strikingly, the Drd2 expression pattern differs between Drd2 reporter rats and Drd2 reporter mice generated by BAC transgene in prefrontal cortex and hippocampus. These results provide fundamental information needed for the study of Drd2 function in rat forebrain. The Drd2::Cre rats generated here may represent a useful tool to study the function of neuronal populations expressing Drd2.
Literature
Bandeira F, Lent R, Herculano-Houzel S (2009) Changing numbers of neuronal and non-neuronal cells underlie postnatal brain growth in the rat. Proc Natl Acad Sci USA 106:14108–14113CrossRefPubMedPubMedCentral
Bean JC, Lin TW, Sathyamurthy A, Liu F, Yin DM, Xiong WC, Mei L (2014) Genetic labeling reveals novel cellular targets of schizophrenia susceptibility gene: distribution of GABA and non-GABA ErbB4-positive cells in adult mouse brain. J Neurosci 34:13549–13566CrossRefPubMedPubMedCentral
Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63:182–217CrossRefPubMed
Boyson SJ, McGonigle P, Molinoff PB (1986) Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci 6:3177–3188CrossRefPubMedPubMedCentral
Charuchinda C, Karobath SP, Palacios M JM (1987) Dopamine D2 receptors in the rat brain: autoradiographic visualization using a high-affinity selective agonist ligand. J Neurosci 7:1352–1360CrossRefPubMedPubMedCentral
Chaudhuri KR, Schapira AH (2009) Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464–474CrossRefPubMed
Chen YJ, Zhang M, Yin DM, Wen L, Ting A, Wang P, Lu YS, Zhu XH, Li SJ, Wu CY et al (2010) ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation. Proc Natl Acad Sci USA 107:21818–21823CrossRefPubMedPubMedCentral
de Oliveira AR, Reimer AE, Brandao ML (2006) Dopamine D2 receptor mechanisms in the expression of conditioned fear. Pharmacol Biochem Behav 84:102–111CrossRefPubMed
Escanilla O, Yuhas C, Marzan D, Linster C (2009) Dopaminergic modulation of olfactory bulb processing affects odor discrimination learning in rats. Behav Neurosci 123:828–833CrossRefPubMedPubMedCentral
Frey U, Matthies SH H (1990) Dopaminergic antagonists prevent long-term maintenance of posttetanic LTP in the CA1 region of rat hippocampal slices. Brain Res 522:69–75CrossRefPubMed
Gangarossa G, Longueville S, De Bundel D, Perroy J, Herve D, Girault JA, Valjent E (2012) Characterization of dopamine D1 and D2 receptor-expressing neurons in the mouse hippocampus. Hippocampus 22:2199–2207CrossRefPubMed
Gaspar P, Bloch B, Le Moine C (1995) D1 and D2 receptor gene expression in the rat frontal cortex: cellular localization in different classes of efferent neurons. Eur J Neurosci 7:1050–1063CrossRefPubMed
Gee S, Ellwood I, Patel T, Luongo F, Deisseroth K, Sohal VS (2012) Synaptic activity unmasks dopamine D2 receptor modulation of a specific class of layer V pyramidal neurons in prefrontal cortex. J Neurosci 32:4959–4971CrossRefPubMedPubMedCentral
Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr, Sibley DR (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429–1432CrossRefPubMed
Giros B, Sokoloff P, Martres MP, Riou JF, Emorine LJ, Schwartz JC (1989) Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature 342:923–926CrossRefPubMed
Gong S, Zheng C, Doughty ML, Losos K, Didkovsky N, Schambra UB, Nowak NJ, Joyner A, Leblanc G, Hatten ME et al (2003) A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425:917–925CrossRefPubMed
Gregory EH, Pfaff DW (1971) Development of olfactory-guided behavior in infant rats. Physiol Behav 6:573–576CrossRefPubMed
Guglielmetti C, Le Blon D, Santermans E, Salas-Perdomo A, Daans J, De Vocht N, Shah D, Hoornaert C, Praet J, Peerlings J et al (2016) Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages. Glia 64:2181–2200CrossRefPubMed
Harrison PJ (2004) The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology 174:151–162CrossRefPubMed
Heiman M, Schaefer A, Gong S, Peterson JD, Day M, Ramsey KE, Suarez-Farinas M, Schwarz C, Stephan DA, Surmeier DJ et al (2008) A translational profiling approach for the molecular characterization of CNS cell types. Cell 135:738–748CrossRefPubMedPubMedCentral
Kempf SJ, Casciati A, Buratovic S, Janik D, von Toerne C, Ueffing M, Neff F, Moertl S, Stenerlow B, Saran A et al (2014) The cognitive defects of neonatally irradiated mice are accompanied by changed synaptic plasticity, adult neurogenesis and neuroinflammation. Mol Neurodegener 9:57CrossRefPubMedPubMedCentral
Khan ZU, Mrzljak L, Gutierrez A, de la Calle A, Goldman-Rakic PS (1998) Prominence of the dopamine D2 short isoform in dopaminergic pathways. Proc Natl Acad Sci USA 95:7731–7736CrossRefPubMedPubMedCentral
Kramer PF, Christensen CH, Hazelwood LA, Dobi A, Bock R, Sibley DR, Mateo Y, Alvarez VA (2011) Dopamine D2 receptor overexpression alters behavior and physiology in Drd2-EGFP mice. J Neurosci 31:126–132CrossRefPubMedPubMedCentral
Landwehrmeyer B, Mengod G, Palacios JM (1993) Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur J Neurosci 5:145–153CrossRefPubMed
Lavian H, Loewenstern Y, Madar R, Almog M, Bar-Gad I, Okun E, Korngreen A (2018) Dopamine receptors in the rat entopeduncular nucleus. Brain Struct Funct 223:2673–2684CrossRefPubMed
Le Moine C, Gaspar P (1998) Subpopulations of cortical GABAergic interneurons differ by their expression of D1 and D2 dopamine receptor subtypes. Brain Res Mol Brain Res 58:231–236CrossRefPubMed
Levey AI, Hersch SM, Rye DB, Sunahara RK, Niznik HB, Kitt CA, Price DL, Maggio R, Brann MR, Ciliax BJ (1993) Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci USA 90:8861–8865CrossRefPubMedPubMedCentral
Lewis DA, Sweet RA (2009) Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J Clin Investig 119:706–716CrossRefPubMedPubMedCentral
Li D, Qiu Z, Shao Y, Chen Y, Guan Y, Liu M, Li Y, Gao N, Wang L, Lu X et al (2013) Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. Nat Biotechnol 31:681–683CrossRefPubMed
Lidow MS, Wang F, Cao Y, Goldman-Rakic PS (1998) Layer V neurons bear the majority of mRNAs encoding the five distinct dopamine receptor subtypes in the primate prefrontal cortex. Synapse 28:10–20CrossRefPubMed
Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, Ng LL, Palmiter RD, Hawrylycz MJ, Jones AR et al (2010) A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci 13:133–140CrossRefPubMed
Manahan-Vaughan D, Kulla A (2003) Regulation of depotentiation and long-term potentiation in the dentate gyrus of freely moving rats by dopamine D2-like receptors. Cereb Cortex 13:123–135CrossRefPubMed
Mansour A, Meador-Woodruff J, Bunzow JR, Civelli O, Akil H, Watson SJ (1990) Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J Neurosci 10:2587–2600CrossRefPubMedPubMedCentral
Mengod G, Martinez-Mir MI, Vilaro MT, Palacios JM (1989) Localization of the mRNA for the dopamine D2 receptor in the rat brain by in situ hybridization histochemistry. Proc Natl Acad Sci USA 86:8560–8564CrossRefPubMedPubMedCentral
Monsma FJ Jr, McVittie LD, Gerfen CR, Mahan LC, Sibley DR (1989) Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature 342:926–929CrossRefPubMed
Moye TB, Rudy JW (1987) Ontogenesis of trace conditioning in young rats: dissociation of associative and memory processes. Dev Psychobiol 20:405–414CrossRefPubMed
Puig MV, Rose J, Schmidt R, Freund N (2014) Dopamine modulation of learning and memory in the prefrontal cortex: insights from studies in primates, rodents, and birds. Front Neural Circuits 8:93CrossRefPubMedPubMedCentral
Puighermanal E, Biever A, Espallergues J, Gangarossa G, De Bundel D, Valjent E (2015) drd2-cre:ribotag mouse line unravels the possible diversity of dopamine d2 receptor-expressing cells of the dorsal mouse hippocampus. Hippocampus 25:858–875CrossRefPubMed
Roth BL, Sheffler DJ, Kroeze WK (2004) Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 3:353–359CrossRefPubMed
Salas M, Schapiro S, Guzman-Flores C (1970) Development of olfactory bulb discrimination between maternal and food odors. Physiol Behav 5:1261–1264CrossRefPubMed
Santana N, Mengod G, Artigas F (2009) Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 19:849–860CrossRefPubMed
Schoppa NE (2006) Synchronization of olfactory bulb mitral cells by precisely timed inhibitory inputs. Neuron 49:271–283CrossRefPubMed
Schultz W (2007) Multiple dopamine functions at different time courses. Annu Rev Neurosci 30:259–288CrossRefPubMed
Sesack SR, Aoki C, Pickel VM (1994) Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci 14:88–106CrossRefPubMedPubMedCentral
Shackman AJ, Salomons TV, Slagter HA, Fox AS, Winter JJ, Davidson RJ (2011) The integration of negative affect, pain and cognitive control in the cingulate cortex. Nat Rev Neurosci 12:154–167CrossRefPubMedPubMedCentral
Shepherd GM, Chen WR, Willhite D, Migliore M, Greer CA (2007) The olfactory granule cell: from classical enigma to central role in olfactory processing. Brain Res Rev 55:373–382CrossRefPubMed
Squire LR (1992) Declarative and nondeclarative memory: multiple brain systems supporting learning and memory. J Cogn Neurosci 4:232–243CrossRefPubMed
Steulet AF, Bernasconi R, Leonhardt T, Martin P, Grunenwald C, Bischoff S, Heinrich M, Bandelier V, Maitre L (1990) Effects of selective dopamine D1 and D2 receptor agonists on the rate of GABA synthesis in mouse brain. Eur J Pharmacol 191:19–27CrossRefPubMed
Stojanovic T, Orlova M, Sialana FJ, Hoger H, Stuchlik S, Milenkovic I, Aradska J, Lubec G (2017) Validation of dopamine receptor DRD1 and DRD2 antibodies using receptor deficient mice. Amino Acids 49:1101–1109CrossRefPubMed
Tamamaki N, Yanagawa Y, Tomioka R, Miyazaki J, Obata K, Kaneko T (2003) Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J Comp Neurol 467:60–79CrossRefPubMed
Tillerson JL, Caudle WM, Parent JM, Gong C, Schallert T, Miller GW (2006) Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor. Behav Brain Res 172:97–105CrossRefPubMed
Tomasella E, Bechelli L, Ogando MB, Mininni C, Di Guilmi MN, De Fino F, Zanutto S, Elgoyhen AB, Marin-Burgin A, Gelman DM (2018) Deletion of dopamine D2 receptors from parvalbumin interneurons in mouse causes schizophrenia-like phenotypes. Proc Natl Acad Sci USA 115:3476–3481CrossRefPubMedPubMedCentral
Tseng KY, O’Donnell P (2007) Dopamine modulation of prefrontal cortical interneurons changes during adolescence. Cereb Cortex 17:1235–1240CrossRefPubMed
Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F (2007) Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol 64:1575–1579CrossRefPubMed
Wang SM, Lee YC, Ko CY, Lai MD, Lin DY, Pao PC, Chi JY, Hsiao YW, Liu TL, Wang JM (2015) Increase of zinc finger protein 179 in response to CCAAT/enhancer binding protein delta conferring an antiapoptotic effect in astrocytes of Alzheimer’s disease. Mol Neurobiol 51:370–382CrossRefPubMed
Wei X, Ma T, Cheng Y, Huang CCY, Wang X, Lu J, Wang J (2018) Dopamine D1 or D2 receptor-expressing neurons in the central nervous system. Addict Biol 23:569–584CrossRefPubMed
Weiner DM, Levey LA, Sunahara RK, Niznik HB, O’Dowd BF, Seeman P, Brann MR (1991) D1 and D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci USA 88:1859–1863CrossRefPubMedPubMedCentral
Wen L, Lu YS, Zhu XH, Li XM, Woo RS, Chen YJ, Yin DM, Lai C, Terry AV Jr, Vazdarjanova A et al (2010) Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc Natl Acad Sci USA 107:1211–1216CrossRefPubMed
Wigstrom H, Gustafsson B (1983) Facilitated induction of hippocampal long-lasting potentiation during blockade of inhibition. Nature 301:603–604CrossRefPubMed
Wong DF, Wagner HN, Tune LE, Dannals RF, Pearlson GD, Links JM, Tamminga CA, Broussolle EP, Ravert HT, Wilson AA et al (1986) Positron emission tomography reveals elevated D2 dopamine-receptors in drug-naive schizophrenics. Science 234:1558–1563CrossRefPubMed
Xu TX, Yao WD (2010) D1 and D2 dopamine receptors in separate circuits cooperate to drive associative long-term potentiation in the prefrontal cortex. Proc Natl Acad Sci USA 107:16366–16371CrossRefPubMedPubMedCentral
Yin DM, Chen YJ, Lu YS, Bean JC, Sathyamurthy A, Shen C, Liu X, Lin TW, Smith CA, Xiong WC et al (2013a) Reversal of behavioral deficits and synaptic dysfunction in mice overexpressing neuregulin 1. Neuron 78:644–657CrossRefPubMedPubMedCentral
Yin DM, Sun XD, Bean JC, Lin TW, Sathyamurthy A, Xiong WC, Gao TM, Chen YJ, Mei L (2013b) Regulation of spine formation by ErbB4 in PV-positive interneurons. J Neurosci 33:19295–19303CrossRefPubMedPubMedCentral
Yokoyama C, Okamura H, Nakajima T, Taguchi J, Ibata Y (1994) Autoradiographic distribution of [3H]YM-09151-2, a high-affinity and selective antagonist ligand for the dopamine D2 receptor group, in the rat brain and spinal cord. J Comp Neurol 344:121–136CrossRefPubMed
Metadata
Title
Genetic labeling reveals temporal and spatial expression pattern of D2 dopamine receptor in rat forebrain
Authors
Qing Yu
Ying-Zi Liu
Yan-Bing Zhu
Yao-Yi Wang
Qian Li
Dong-Min Yin
Publication date
01-04-2019
Publisher
Springer Berlin Heidelberg
Published in
Brain Structure and Function / Issue 3/2019
Print ISSN: 1863-2653
Electronic ISSN: 1863-2661
DOI
https://doi.org/10.1007/s00429-018-01824-2

Other articles of this Issue 3/2019

Brain Structure and Function 3/2019 Go to the issue

Original Article

Sledge runner fasciculus: anatomic architecture and tractographic morphology

Review

The dark matter of the brain

Original Article

Reconstructing imagined letters from early visual cortex reveals tight topographic correspondence between visual mental imagery and perception

Original Article

The lateral preoptic area and ventral pallidum embolden behavior

Original Article

Dissociating motor–speech from lexico-semantic systems in the left frontal lobe: insight from a series of 17 awake intraoperative mappings in glioma patients

Review

The Structural Model: a theory linking connections, plasticity, pathology, development and evolution of the cerebral cortex